Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas (Q46630773)
Jump to navigation
Jump to search
scientific article published on 23 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas |
scientific article published on 23 April 2008 |
Statements
1 reference
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas (English)
1 reference
A Tosoni
1 reference
E Franceschi
1 reference
M Ermani
1 reference
R Bertorelle
1 reference
L Bonaldi
1 reference
V Blatt
1 reference
23 April 2008
1 reference
1 reference
89
1 reference
2
1 reference
179-185
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference